1. Home
  2. PBMWW vs TBB Comparison

PBMWW vs TBB Comparison

Compare PBMWW & TBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • TBB
  • Stock Information
  • Founded
  • PBMWW N/A
  • TBB N/A
  • Country
  • PBMWW Canada
  • TBB United States
  • Employees
  • PBMWW 10
  • TBB 160700
  • Industry
  • PBMWW
  • TBB Telecommunications Equipment
  • Sector
  • PBMWW
  • TBB Telecommunications
  • Exchange
  • PBMWW Nasdaq
  • TBB Nasdaq
  • Market Cap
  • PBMWW N/A
  • TBB N/A
  • IPO Year
  • PBMWW N/A
  • TBB 2017
  • Fundamental
  • Price
  • PBMWW $0.01
  • TBB $24.67
  • Analyst Decision
  • PBMWW
  • TBB
  • Analyst Count
  • PBMWW 0
  • TBB 0
  • Target Price
  • PBMWW N/A
  • TBB N/A
  • AVG Volume (30 Days)
  • PBMWW N/A
  • TBB N/A
  • Earning Date
  • PBMWW N/A
  • TBB N/A
  • Dividend Yield
  • PBMWW N/A
  • TBB N/A
  • EPS Growth
  • PBMWW N/A
  • TBB N/A
  • EPS
  • PBMWW N/A
  • TBB N/A
  • Revenue
  • PBMWW N/A
  • TBB N/A
  • Revenue This Year
  • PBMWW N/A
  • TBB N/A
  • Revenue Next Year
  • PBMWW N/A
  • TBB N/A
  • P/E Ratio
  • PBMWW N/A
  • TBB N/A
  • Revenue Growth
  • PBMWW N/A
  • TBB N/A
  • 52 Week Low
  • PBMWW N/A
  • TBB N/A
  • 52 Week High
  • PBMWW N/A
  • TBB N/A
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • TBB 62.87
  • Support Level
  • PBMWW N/A
  • TBB $24.47
  • Resistance Level
  • PBMWW N/A
  • TBB $24.79
  • Average True Range (ATR)
  • PBMWW 0.00
  • TBB 0.14
  • MACD
  • PBMWW 0.00
  • TBB -0.04
  • Stochastic Oscillator
  • PBMWW 0.00
  • TBB 53.95

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About TBB AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The firm is the third-largest US wireless carrier, connecting 72 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 16% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 11% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&T also has a sizable presence in Mexico, with 23 million customers, but this business only accounts for 4% of revenue. The firm still holds a 70% equity stake in satellite television provider DirecTV but does not consolidate this business in its financial statements.

Share on Social Networks: